Tykerb is the brand name for a new anti-cancer medication called lapatinib. Tykerb works by inhibiting kinase proteins in cells which interferes with the growth of cancer cells. Tykerb is used in combination with another anti-cancer drug called capecitabine (Xeloda), for the treatment of advanced breast cancer that is positive for the HER2 protein.